Nu Skin Director Shen to Exit Board

Nu Skin Enterprises, Inc. (NYSE:NUS), a global direct selling company currently trading at $8.16 with a market cap of $406 million, announced today that board member Zheqing (Simon) Shen will not seek re-election at the upcoming 2025 Annual Meeting of Stockholders. Shen’s departure is attributed to other professional commitments. The company expressed its appreciation for Shen’s years of service on the board. According to InvestingPro analysis, Nu Skin appears undervalued at current levels, with several positive indicators including a 25-year track record of consistent dividend payments.

The announcement, based on a recent SEC filing, marks a change in the composition of Nu Skin’s leadership team. Shen’s decision to step down will take effect at the next annual meeting, the date of which has not been specified in the filing. Nu Skin Enterprises, recognized for its personal care products and dietary supplements, has not yet announced a successor or detailed any changes to board structure following Shen’s departure. The company maintains a "FAIR" financial health score according to InvestingPro, which offers 8 additional key insights about the company’s prospects.

Nu Skin, headquartered in Provo, Utah, operates in the wholesale distribution of health and wellness products, maintaining impressive gross profit margins of 70.5%. While not profitable in the last twelve months, analysts expect the company to return to profitability this year. The company has been a player in the industry since its incorporation in Delaware and has shown recent momentum with a 19.4% year-to-date price return.

The filing did not disclose any further changes to Nu Skin’s executive team or board of directors. Shen’s exit is a routine part of corporate governance, reflecting the natural turnover within high-level corporate structures. As such events are of interest to investors and stakeholders, the company has fulfilled its regulatory requirement to inform the public of these changes through the SEC filing.

This development comes without additional context regarding the company’s future strategic direction or any potential impact on its operations. Nu Skin Enterprises has not provided further comment on the matter beyond the formal acknowledgment of Shen’s contributions and service.

The information for this report is sourced from an 8-K filing with the Securities and Exchange Commission.

In other recent news, Nu Skin Enterprises reported its preliminary fourth-quarter revenue for 2024, which reached the high end of the company’s guidance range. This announcement precedes their participation in the ICR Conference, where further financial details are expected to be disclosed. Additionally, Nu Skin completed a significant transaction through its subsidiary, Rhyz Inc., selling the Mavely affiliate marketing platform to Later for approximately $250 million. This deal is anticipated to enhance Nu Skin’s capabilities and provide funds for debt reduction and innovation.

DA Davidson has revised its price target for Nu Skin, increasing it to $7.50 following fourth-quarter earnings that exceeded expectations, despite a 4.7% decline in constant currency sales. The firm maintained a neutral rating on the stock, noting ongoing challenges in the Chinese and Korean markets. Previously, DA Davidson had reduced the price target to $7.00 due to weaker-than-expected third-quarter performance and reduced guidance for the full year. Analysts from DA Davidson expressed cautious optimism, suggesting potential revenue improvements in 2025, though uncertainties remain regarding when Nu Skin’s core business might stabilize.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.